Stevanato Group S.p.A. (NYSE:STVN) Given Average Rating of “Buy” by Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVNGet Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating on the company.

Several equities research analysts have issued reports on the stock. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Finally, Wolfe Research began coverage on Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target for the company.

View Our Latest Research Report on STVN

Insiders Place Their Bets

In other Stevanato Group news, Director Karen Flynn sold 1,493 shares of Stevanato Group stock in a transaction dated Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the sale, the director owned 5,757 shares in the company, valued at €98,387.13. The trade was a 20.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Donald E. Morel, Jr. sold 1,493 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director directly owned 37,424 shares of the company’s stock, valued at approximately €639,576.16. This represents a 3.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 5,972 shares of company stock worth $102,061 over the last 90 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in STVN. Royal Bank of Canada raised its holdings in Stevanato Group by 10.8% in the first quarter. Royal Bank of Canada now owns 437,284 shares of the company’s stock valued at $8,930,000 after buying an additional 42,731 shares during the period. Sei Investments Co. grew its stake in Stevanato Group by 16.9% during the second quarter. Sei Investments Co. now owns 231,244 shares of the company’s stock worth $5,649,000 after buying an additional 33,419 shares during the period. Raymond James Financial Inc. increased its position in shares of Stevanato Group by 21.2% in the second quarter. Raymond James Financial Inc. now owns 567,803 shares of the company’s stock worth $13,871,000 after acquiring an additional 99,328 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Stevanato Group by 14.2% in the second quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock worth $17,316,000 after acquiring an additional 87,942 shares in the last quarter. Finally, Bamco Inc. NY raised its stake in shares of Stevanato Group by 2.1% in the 2nd quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock valued at $46,125,000 after acquiring an additional 39,528 shares during the period.

Stevanato Group Stock Up 0.5%

Shares of NYSE:STVN opened at €19.24 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. Stevanato Group has a 52-week low of €12.89 and a 52-week high of €28.00. The stock’s fifty day simple moving average is €18.26 and its 200-day simple moving average is €17.05. The company has a market capitalization of $5.83 billion, a P/E ratio of 32.61, a P/E/G ratio of 1.77 and a beta of 0.78.

Stevanato Group (NYSE:STVNGet Free Report) last posted its quarterly earnings data on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The company had revenue of €273.57 million for the quarter. During the same period in the previous year, the company posted $0.10 EPS. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. As a group, equities research analysts forecast that Stevanato Group will post 0.68 earnings per share for the current fiscal year.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

Read More

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.